Amgen Inc.

Amgen Inc.

Amgen Inc.

Amgen engages in the development of human therapeutic products in supportive ofcancer care, inflammation, nephrology and bone diseases.
Founded
1985
Raised
$12M
Follow us
Featured on
13 May 2020

QurAlis Raises $42M in Series A Financing

FinSMEs
+1
02 Apr 2020
19 Feb 2020
$10,000,000
Venture capital (Series A)

EnClear Therapies Raises $10M in Series A Financing

FinSMEs
+2
21 Mar 2019

Imago BioSciences raised $40 mln

PE HUB
+1
27 Jul 2018

Biotech Company Alector Raises $133M in Series E Financing

FinSMEs
+1
09 May 2018

Akili Grabs $55M, Seeking FDA Approval of First Video Game Therapy

Xconomy
+3
05 Apr 2018
27 Feb 2018
$53,000,000
Venture capital (Series A)

All-star team of synthetic biologists raise $53 million for cancer therapy startup Senti

TechCrunch
+2
06 Dec 2017
$49,500,000
Venture capital (Series A)
08 Nov 2017
$25,000,000
Venture capital (Series B)
Amgen Ventures, Salamander Investment Netherlands
30 Oct 2017
$30,000,000
Venture capital (Series A)
07 Sep 2017
$240,000,000
Venture capital (Series B)

WuXi NextCODE racks up $240 mln Series B

PE HUB
+1
23 Aug 2017
$6,000,000
Venture capital (Series C)

GNS Healthcare Adds $6M, Led by Amgen, for Machine Learning Tech

Xconomy
+1
25 Apr 2017
$29,000,000
Venture capital (Series C)

GV joins $29 million investment into Science 37 to bring clinical trials to the home

VentureBeat
+1